BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
Coagulation
,
HIV infection
,
Lymphocyte
,
Nosology
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NUP160
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
T Lymphocyte (regulatory) of peripheral blood
Basophil of peripheral blood
Hematopoietic stem cell of bone marrow
Ileum mucosa
T Lymphocyte (CD8+) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The nucleoporin NUP160 and NUP96 regulate nucleocytoplasmic export of mRNAs and participate in ethyl…
Nucleoporin 160 Regulates Flowering through Anchoring HOS1 for Destabilizing CO in Arabidopsis.
Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis.
NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma.
NUP160 knockdown inhibits the progression of diabetic nephropathy in vitro and in vivo.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for NUP160
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ